Conmed (CNMD) Other Non-Current Liabilities (2016 - 2026)
Conmed filings provide 17 years of Other Non-Current Liabilities readings, the most recent being $63.0 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 16.53% to $63.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $63.0 million, a 16.53% decrease, with the full-year FY2025 number at $63.9 million, down 26.01% from a year prior.
- Other Non-Current Liabilities hit $63.0 million in Q1 2026 for Conmed, down from $63.9 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $218.1 million in Q3 2022 to a low of $41.8 million in Q1 2022.
- Median Other Non-Current Liabilities over the past 5 years was $107.3 million (2024), compared with a mean of $113.4 million.
- Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 373.8% in 2022 and later tumbled 41.41% in 2024.
- Conmed's Other Non-Current Liabilities stood at $203.7 million in 2022, then crashed by 40.58% to $121.0 million in 2023, then dropped by 28.7% to $86.3 million in 2024, then decreased by 26.01% to $63.9 million in 2025, then decreased by 1.3% to $63.0 million in 2026.
- The last three reported values for Other Non-Current Liabilities were $63.0 million (Q1 2026), $63.9 million (Q4 2025), and $71.7 million (Q3 2025) per Business Quant data.